AU9140891A - Synthetic immunoactive peptides having immunomodulating and therapeutic activities - Google Patents

Synthetic immunoactive peptides having immunomodulating and therapeutic activities

Info

Publication number
AU9140891A
AU9140891A AU91408/91A AU9140891A AU9140891A AU 9140891 A AU9140891 A AU 9140891A AU 91408/91 A AU91408/91 A AU 91408/91A AU 9140891 A AU9140891 A AU 9140891A AU 9140891 A AU9140891 A AU 9140891A
Authority
AU
Australia
Prior art keywords
immunomodulating
therapeutic activities
synthetic
immunoactive peptides
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU91408/91A
Inventor
Andrew Atkin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IMMUNODYNAMICS Inc
Original Assignee
IMMUNODYNAMICS Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IMMUNODYNAMICS Inc filed Critical IMMUNODYNAMICS Inc
Publication of AU9140891A publication Critical patent/AU9140891A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57581—Thymosin; Related peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/66—Thymopoietins
    • C07K14/662—Thymopoietins at least 1 amino acid in D-form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU91408/91A 1990-11-23 1991-11-22 Synthetic immunoactive peptides having immunomodulating and therapeutic activities Abandoned AU9140891A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61749490A 1990-11-23 1990-11-23
US617494 1990-11-23

Publications (1)

Publication Number Publication Date
AU9140891A true AU9140891A (en) 1992-06-25

Family

ID=24473862

Family Applications (1)

Application Number Title Priority Date Filing Date
AU91408/91A Abandoned AU9140891A (en) 1990-11-23 1991-11-22 Synthetic immunoactive peptides having immunomodulating and therapeutic activities

Country Status (3)

Country Link
EP (1) EP0563212A1 (en)
AU (1) AU9140891A (en)
WO (1) WO1992009628A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU653838B2 (en) * 1991-06-03 1994-10-13 Immunobiology Research Institute, Inc. Immunoregulatory and neuroregulatory pentapeptides

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5589458A (en) * 1992-11-13 1996-12-31 Thomas Jefferson University Compounds that inhibit T cell proliferation and methods for using the same
US6017719A (en) * 1994-06-14 2000-01-25 Nexell Therapeutics, Inc. Positive and positive/negative cell selection mediated by peptide release
GB9421180D0 (en) * 1994-10-20 1994-12-07 Peptide Therapeutics Ltd Immunomodulatory Polypeptides
GB9425582D0 (en) * 1994-12-19 1995-02-15 Iaf Biochem Int Peptides having immunomodulatory activity
RU2107691C1 (en) * 1995-03-02 1998-03-27 Дейгин Владислав Исакович Peptide and method for its preparation
US6103699A (en) * 1996-06-07 2000-08-15 Immunotech Developments Inc. Peptide, a method for its preparation and a pharmaceutical composition containing the peptide
US6159940A (en) * 1996-02-28 2000-12-12 Immunotech Developments Inc. Method for modulating hemopoiesis
US6046167A (en) * 1998-03-25 2000-04-04 University Of Cincinnati Peptide YY analogs
US6734287B1 (en) 1998-04-09 2004-05-11 Idexx Laboratories, Inc. Specific binding proteins for treating canine allergy
EP0955311A3 (en) * 1998-04-09 2000-08-16 Idexx Laboratories, Inc. Peptide vaccine for canine allergy
CA2329148C (en) * 1999-03-30 2012-05-29 Idexx Laboratories, Inc. Specific binding proteins for treating canine allergy
AU4053600A (en) * 1999-03-30 2000-10-16 Idexx Laboratories, Inc. Peptide vaccine for canine allergy
US7129052B1 (en) 2000-07-12 2006-10-31 The United States Of America As Represented By The Department Of Health And Human Services Peptides and their utility in modulation of behavior of cells expressing α3β1 integrins
US20050084967A1 (en) 2002-06-28 2005-04-21 Xcyte Therapies, Inc. Compositions and methods for eliminating undesired subpopulations of T cells in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation
CN113631566A (en) * 2019-02-08 2021-11-09 路博润先进材料公司 Compounds useful for the treatment and/or care of the skin, hair, nails and/or mucous membranes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4002740A (en) * 1975-08-21 1977-01-11 Gideon Goldstein Tridecapeptide compositions and methods
DE3100974A1 (en) * 1980-01-18 1982-01-21 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Medicaments having immunoregulating action which contain thymosin alpha 1 fragments, and thymosin alpha 1 fragments
US4397842A (en) * 1980-03-13 1983-08-09 Ortho Pharmaceutical Corporation Peptides having thymopoietin-like activity
US4659694A (en) * 1983-10-27 1987-04-21 Hoffmann-La Roche Inc. Prothymosin alpha
US4547489A (en) * 1984-06-11 1985-10-15 Ortho Pharmaceutical Corporation Conformationally restricted thymopentin-like compounds
IT1226552B (en) * 1988-07-29 1991-01-24 Ellem Ind Farmaceutica IMMUNOSTIMULANT PEPTIDES.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU653838B2 (en) * 1991-06-03 1994-10-13 Immunobiology Research Institute, Inc. Immunoregulatory and neuroregulatory pentapeptides

Also Published As

Publication number Publication date
EP0563212A4 (en) 1994-04-27
EP0563212A1 (en) 1993-10-06
WO1992009628A1 (en) 1992-06-11

Similar Documents

Publication Publication Date Title
AU8947291A (en) A synthetic peptide and its uses
EP0406428A4 (en) Peptide derivatives and their use
AU652928B2 (en) Lipid-selective antioxidants and their preparation and use
AU624307B2 (en) Lift-through head and swivel
EP0503301A3 (en) Peptide derivatives and application thereof
AU9140891A (en) Synthetic immunoactive peptides having immunomodulating and therapeutic activities
GB9013410D0 (en) Polypeptide and its use
EP0445801A3 (en) Peptide and its use
AU633294B2 (en) Motilin-like polypeptide and use thereof
GB9117954D0 (en) Multriaxis robot and use thereof
AU1114192A (en) Fabric and structure
AU1435695A (en) Recombinant human thymopoietin proteins and uses therefor
NZ227594A (en) Human interleukin-1alpha and preparations thereof
AU647559B2 (en) Pyrimidinyl- and triazinyl-salicylamides and their use and preparation
IL106436A0 (en) Synthetic polypeptides and their use
EP0456138A3 (en) Peptide-amidase and its application
AU8603591A (en) Peptide and its use
EP0540575A4 (en) Human meg-csf protein and methods
IL105873A0 (en) Pyrimidinyl-and triazinyl-salicyl-and-picolyl-amides and the use and preparation thereof
ZA942246B (en) Novel imidazolo-quinoxalinones their preparation and use
AU3990889A (en) Novel peptide and anti-dementia agent
AU8110191A (en) Novel spergualin-related compound and use thereof
AU7951791A (en) Human and rat thymopoietin
GB9010740D0 (en) Peptide compounds and their preparation
GB9026254D0 (en) Peptide compound and its preparation